MedPath

A Single Center Clinical Trial to Assess Viability of High Risk Donor Livers using Hypothermic and Normothermic Machine Perfusion with Rewarming Phase Prior to Transplantatio

Recruiting
Conditions
normothermic machine preservationnormothermic machine perfusionex-situ viability testing liver transplantationnormotherme machine preservatienormtoherme machine perfusielever transplantatie
Registration Number
NL-OMON19890
Lead Sponsor
R.J. Porte, r.j.porte@umcg.nl, +31503619027 University Medical Center Groningen, Department of Surgery, P.O. Box 30.001, 9700 RB Groningen, the Netherlands
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Recipient

-Adult patients (≥ 18 years old)

Exclusion Criteria

Recipient

-Simultaneous participation in another clinical trial that might possibly influence this trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The feasibility, and reliability of ex-situ viability testing of high risk donor livers using a protocol combining DHOPE, gradual rewarming and NMP, by assessing graft survival at 3 months after transplantation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath